Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials for Multivessel PCI Versus Culprit Artery Only PCI in STEMI Without Cardiogenic Shock

Goldstein, 2000, Multiple complex coronary plaques in patients with acute myocardial infarction, N Engl J Med, 343, 915, 10.1056/NEJM200009283431303 Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ac... - PubMed - NCBI. Available at: https://www-ncbi-nlm-nih-gov.ezproxy.rochesterregional.org:2443/pubmed/?term=Impact+of+multivessel+disease+on+reperfusion+success+and+clinical+outcomes+in+patients+undergoing+primary+percutaneous+coronary+intervention+for+acute+myocardial+infarction. Accessed November 21, 2019. Rigattieri, 2008, Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty, J Interv Cardiol, 21, 1, 10.1111/j.1540-8183.2007.00317.x Hannan, 2010, Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease, JACC Cardiovasc Interv, 3, 22, 10.1016/j.jcin.2009.10.017 Toma, 2010, Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial, Eur Heart J, 31, 1701, 10.1093/eurheartj/ehq129 Hochman, 1999, Early revascularization in acute myocardial infarction complicated by cardiogenic shock, N Engl J Med, 341, 625, 10.1056/NEJM199908263410901 Hochman, 2006, Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction, J Am Med Assoc, 295, 2511, 10.1001/jama.295.21.2511 O'Gara, 2013, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 127, e362 Levine, 2016, 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for t, J Am Coll Cardiol, 67, 1235, 10.1016/j.jacc.2015.10.005 StephanWindecker, 2015, 2014 ESC/EACTS guidelines on myocardial revascularization, Rev Esp Cardiol (Engl Ed), 68, 144 Neumann, 2019, 2018 ESC/EACTS guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)], G Ital Cardiol (Rome), 20, 1 Vlaar, 2011, Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis, J Am Coll Cardiol, 58, 692, 10.1016/j.jacc.2011.03.046 Wald, 2013, Randomized trial of preventive angioplasty in myocardial infarction, N Engl J Med, 369, 1115, 10.1056/NEJMoa1305520 Anantha Narayanan, 2016, What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials, Int J Cardiol, 216, 18, 10.1016/j.ijcard.2016.04.054 Mehta, 2019, Complete revascularization with multivessel PCI for myocardial infarction, N Engl J Med, 1411, 10.1056/NEJMoa1907775 2019 Welch, 2016, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, J Clin Epidemiol, 26, b2700 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Med, 6, 10.1371/journal.pmed.1000100 Collaboration, 2014, Review manager v5.3, Cochrane Collab Higgins, 2003, Measuring inconsistency in meta-analyses, Br Med J, 327, 557, 10.1136/bmj.327.7414.557 Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark. 2011. p. 1–115. Available from www.ctu.dk/tsa. Wetterslev, 2008, Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis, J Clin Epidemiol, 61, 64, 10.1016/j.jclinepi.2007.03.013 Wetterslev, 2009, Estimating required information size by quantifying diversity in random-effects model meta-analyses, BMC Med Res Methodol, 9, 86, 10.1186/1471-2288-9-86 Smits, 2017, Fractional flow reserve-guided multivessel angioplasty in myocardial infarction, N Engl J Med, 376, 1234, 10.1056/NEJMoa1701067 Politi, 2010, A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up, Heart, 96, 662, 10.1136/hrt.2009.177162 Ghani, 2012, Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial, Netherlands Hear J, 20, 347, 10.1007/s12471-012-0281-y Engstrøm, 2015, Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3 - PRIMULTI): an open-label, randomised controlled trial, Lancet, 386, 665, 10.1016/S0140-6736(15)60648-1 Di Mario, 2004, Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoatTM for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study, Int J Cardiovasc Intervent, 6, 128, 10.1080/14628840310030441 Hlinomaz, 2015, Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularisation versus conservative strategy. Prague-13 trial, Present Eur May, 17, 214 Gershlick, 2015, Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for stemi and multivessel disease: the CvLPRIT trial, J Am Coll Cardiol, 65, 963, 10.1016/j.jacc.2014.12.038 Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, 343, 10.1136/bmj.d5928 Garcia, 2019, Metaanalysis of multivessel vs culprit artery only percutaneous coronary intervention in ST elevation myocardial infarction, Ochsner J, 19, 107, 10.31486/toj.18.0033 Bangalore, 2018, Meta-analysis of culprit-only versus multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel coronary disease, Am J Cardiol, 121, 529, 10.1016/j.amjcard.2017.11.022 Ffr-gUidance for compLete Non-cuLprit REVASCularization (FULL REVASC). https://clinicaltrials.gov/ct2/show/NCT02862119.